References
- Horváth IP, Csétenyi J, Kerpel-Fronius S, Hindy I, Eckhardt S. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man 1. Metabolism of DBD. Eur J Cancer 1979; 15: 337–344
- Csétenyi J, Áfra D, Kerpel-Fronius S, Horváth IP, Eckhardt S. The distribution of labeled dibromodulcitol in the central nervous system of patients with brain tumour. EurJ Cancer Clin Oncol 1983; 19: 1389–1392
- Boczan G. Experiments with dibromodulcitol in malignant brain tumors. Minerva Neurochir 1969; 13: 254–256
- Burger P C, Mahaley M S, Dubka L, Vogel F S. The morphologic effects of radiation administered therapeutically for intracranial gliomas. Cancer 1979; 44: 1256–1272
- Afra D, Kocsis B, Dobay J, Eckhardt S. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 1983; 59: 106–110
- Eagan R T, Dinapoli R P, Hermann R C, Groover R V, Layton D D, Scott M. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation. Cancer Treat Rep 1982; 66: 1647–1649